American Journal of Cardiology
Volume 103, Issue 11 , Pages 1525-1529 , 1 June 2009

Frequency and Prognostic Significance of Pericarditis Following Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

  • Massimo Imazio, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • Corresponding Author InformationCorresponding author: Tel: 39-011-4393391; fax: 39-011-4393334
    • ,
  • Alessandro Negro, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Riccardo Belli, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Federico Beqaraj, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Davide Forno, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Massimo Giammaria, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Rita Trinchero, MD

      Affiliations

    • Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    • ,
  • Yehuda Adler, MD

      Affiliations

    • Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • David Spodick, MD

      Affiliations

    • Medical Services, St. Vincent Hospital, Worcester Medical Center, Worcester, Massachusetts

Received 30 November 2008 ,Revised 26 January 2009 ,Accepted 26 January 2009.

References 

  1. Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK, et al. Pericarditis in acute myocardial infarction: characterization and clinical significance. Am Heart J. 1989;117:86–92
  2. Dubois C, Smeets JP, Demoulin JC, Pierard L, Henrard L, Pretson L, et al. Frequency and clinical significance of pericardial friction rubs in the acute phase of myocardial infarction. Eur Heart J. 1985;6:766–768
  3. Wall TC, Califf RM, Harrelson-Woodlief L, Mark DB, Honan M, Abbotsmith CW, et al Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. Am J Cardiol. 1990;66:1418–1421
  4. Correale E, Maggioni AP, Romano S, Ricciardiello V, Battista R, Salvarola G, et al. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Am J Cardiol. 1993;71:1377–1381
  5. Shahar A, Hod H, Barabash GM, Kaplinsky E, Motro M. Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology. 1994;85:255–258
  6. Heggunje PS, Harjai KJ, Stone GW, Mehta RH, Marsalese DL, Boura JA, et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1400–1407
  7. Oliva PB, Hammill SC, Edwards WD. Electrocardiographic diagnosis of postinfarction regional pericarditis (Ancillary observations regarding the effect of reperfusion on the rapidity and amplitude of T wave inversion after acute myocardial infarction). Circulation. 1993;88:896–904
  8. Oliva PB, Hammill SC, Talana JVT. Wave changes consistent with epicardial involvement in acute myocardial infarction (Observations in patients with a postinfarction pericardial effusion without clinically recognized postinfarction pericarditis). J Am Coll Cardiol. 1994;24:1073–1077
  9. Spodick DH. Acute pericarditis: current concepts and practice. JAMA. 2003;289:1150–1153
  10. Oliva PB, Hammill SC, Talano JV. Effect of definition on incidence of postinfarction pericarditis. Circulation. 1994;90:1537–1541
  11. Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397–402
  12. Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990;336:65–71
  13. Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes-Genis A, et al. Colchicine treatment for recurrent pericarditis (A decade of experience). Circulation. 1998;97:2183–2185
  14. Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (Colchicine for Recurrent Pericarditis) trial. Arch Intern Med. 2005;165:1987–1991
  15. Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for Acute Pericarditis (COPE) trial. Circulation. 2005;112:2012–2016
  16. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J. 2004;25:587–610
  17. Hammerman H, Alker KJ, Schoen FJ, Kloner RA. Morphologic and functional effects of piroxicam on myocardial scar formation after coronary occlusion in dogs. Am J Cardiol. 1984;53:604–607
  18. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation. 1976;53:I204
  19. Silverman HS, Pfeifer MP. Relation between use of antiinflammatory agents and left ventricular free wall rupture during acute myocardial infarction. Am J Cardiol. 1987;59:363–364
  20. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110:e82–e292
  21. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the ACC/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the AAFP: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation. 2007;2008:296–329
  22. Berman J, Haffajee CI, Alpert JS. Therapy of symptomatic pericarditis after myocardial infarction: retrospective and prospective studies of aspirin, indomethacin, prednisone, and spontaneous resolution. Am Heart J. 1981;101:750–753
  23. Madsen SM, Jakobsen TJ. Colchicine treatment of recurrent steroid-dependent pericarditis in a patient with post-myocardial-infarction syndrome (Dressler's syndrome). Ugeskr Laeger. 1992;154:3427–3428

PII: S0002-9149(09)00539-6

doi: 10.1016/j.amjcard.2009.01.366

American Journal of Cardiology
Volume 103, Issue 11 , Pages 1525-1529 , 1 June 2009

Article Tools

* Image Usage & Resolution